Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome

Last updated: July 10, 2025
Sponsor: University of Michigan
Overall Status: Completed

Phase

N/A

Condition

Stomach Discomfort

Colic

Gastrointestinal Diseases And Disorders

Treatment

a low FODMAP diet for 4 weeks

Clinical Study ID

NCT04542018
HUM00166423
K23DK129327
  • Ages 18-65
  • All Genders

Study Summary

This research is studying whether changing an individual's diet may have an impact as a treatment or outcome for Irritable Bowel Syndrome (IBS). This research will show if diet might play a role in triggering changes that may cause IBS. This study is being done to learn if a low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols) diet causes changes in the colon lining which mediates improvement in IBS symptoms.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Normal serum studies including serum tissue-transglutaminase antibodies, thyroid stimulating hormone levels, C-reactive protein or fecal calprotectin, complete blood count since the onset of symptoms.

  • Normal stool studies including, ova and parasites since the onset of symptoms

  • IBS-SSS score of ≥175 at the end of the 7-day screening period

In case of presence of any alarm features and/or elevated inflammatory markers (C-reactive protein or fecal calprotectin), patients will be eligible if they have been excluded for inflammatory bowel disease with colonoscopy in the last one year.

Exclusion criteria

  • individuals already on a LFD or other dietary restriction such as gluten free diet within the past 6 months

  • individuals with any known food allergy or insulin-dependent diabetes

  • known history of celiac disease, inflammatory bowel disease or microscopic colitis

  • prior small bowel or colonic surgery or cholecystectomy

  • pregnant patients

  • Antibiotics in the past 3 months

  • Those who regularly use mast cell stabilizers or anti-histaminic or non-steroidal anti-inflammatory agents (NSAIDs) excluding daily baby aspirin or steroids or bile-acid binder.

Study Design

Total Participants: 48
Treatment Group(s): 1
Primary Treatment: a low FODMAP diet for 4 weeks
Phase:
Study Start date:
August 03, 2020
Estimated Completion Date:
May 15, 2024

Connect with a study center

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts 02215
    United States

    Site Not Available

  • University of Michigan

    Ann Arbor, Michigan 48109
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.